Andrew Penman Email & Phone Number
Chief Executive Officer @ LIA Diagnostics
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Andrew Penman Location
- Birmingham, AL, US
Andrew Penman Work
- 2021 -now Chief Executive Officer @
- 2016 -now Managing Partner @ Preclinical Consulting
- 2018 -2021 Director, Life Sciences @ Cubed Labs
- 2016 -2017 Chief Technology Officer @ Advanced Tear Diagnostics
- 2008 -2016 Vice President, Drug Development @
- 2006 -2008 Vice President, Preclinical Development @
- 2005 -2006 President, Preclinical Technologies @
- 2003 -2005 Vice President, Bioanalytical Sciences and DMPK @
- 2002 -2003 Director, Drug Metabolism and Biodisposition @
- 1999 -2002 President and CEO @ Cephac Europe SA
- 1994 -1998 Director, Bioanalysis @
- 1991 -1994 Group Leader, Drug Metabolism @ Syntex
Andrew Penman Education
- The University of Kent
Doctor of Philosophy (PhD) (Physical Chemistry)
1987-1991 - Heriot-Watt University
BSc (Hons) (Chemistry)
1980-1984
Andrew Penman Skills
- Management
- Medical Devices
- Program Management
- Process Simulation
- IND
- Pharmacology
- Toxicology
- Bioanalysis
- Pharmacokinetics
- Formulation
- Drug Metabolism
- Regulations
- In Vitro
- PMA
- Clinical Development
- Drug Discovery
- Drug Development
- GLP
- Pharmaceutical Industry
- Biotechnology
- FDA
- Validation
- Oncology
- Biochemistry
- In Vivo
- R&D
- Pharmaceutics
- Drug Delivery
- Biopharmaceuticals
- Mass Spectrometry
- Lifesciences
- Immunology
- Immunoassays
- Analytical Chemistry
- Commercialization
- HPLC
- Technology Transfer
- Regulatory Affairs
- Medicinal Chemistry
- Vaccines
- Protein Chemistry
- Clinical Trials
- Sop
- Infectious Diseases
- Regulatory Submissions
- CRO
- Life Sciences
- CRO Management
- U.S. Food and Drug Administration (FDA)
- Good Laboratory Practice (GLP)
- Good Laboratory Practice Glp
- Change Management
- JavaScript
- U.S. Food And Drug Administration Fda
- Research
- u.s. Food and Drug Administration
- Good Laboratory Practice
Andrew Penman Summary
- Andrew Penman, based in Birmingham, AL, US, is currently a Chief Executive Officer at LIA Diagnostics. Andrew Penman brings experience from previous roles at Preclinical Consulting, Cubed Labs, Advanced Tear Diagnostics and Southern Research Institute. Andrew Penman holds a 1987 - 1991 Doctor of Philosophy (PhD) in Physical Chemistry @ The University of Kent. With a robust skill set that includes Management, Medical Devices, Program Management, Process Simulation, IND and more. Andrew Penman has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Andrew Penman?
Find contact details for 700 million professionals.
Others Named Andrew Penman
Andrew Penman
Chief Executive Officer
Birmingham, AL, US
Andrew Penman
Partner
Washington, DC, US
Andrew Penman
Head of Investment Funds Research, Private
Melbourne, VIC, AU
Andrew Penman
Configuration Manager
Newcastle upon Tyne, GB
Andrew Penman
Purchasing and Production Planner
Melbourne, VIC, AU
Andrew Penman
Director, Digital Learning Development
Aberdeen, GB
Andrew Penman
Director | Academic Registry
Guildford, England, GB
Top LIA Diagnostics Employees
Andrew Penman
Chief Executive Officer
Birmingham, AL, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co